L.ChangT
At JosephCareRX, our team emphasizes that prior authorization is an important part of the process to ensure that the patients treatment is effective, necessary, and covered by insurance
Retatrutide is an investigational GIP, GLP-1, and glucagon triple receptor agonist not yet approved by the MHRA or EMA
Common Side Effects of GLP-1 Medications Like any medication, GLP-1 treatments may cause side effects, which is why a real-time medical consultation, and ongoing monitoring by experienced doctors, are needed to ensure they are appropriately prescribed
While early reports suggest microdosing may help some patients, large-scale clinical trials are needed to validate these claims
These drugs are FDA approved and backed by decades of research showing they lower blood sugar and support significant weight loss